Douglas Miehm
Stock Analyst at RBC Capital
(0)
# 4194
Out of 5,293 analysts
44
Total ratings
35.71%
Success rate
-10.06%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
LGND Ligand Pharmaceutica... | Maintains: Outperform | 130 140 | 107.43 | 30.32% | 4 | Nov 12, 2024 | |
BHC Bausch Health Compan... | Maintains: Sector Perform | 10 11 | 6.14 | 79.15% | 18 | Nov 1, 2024 | |
BLCO Bausch & Lomb | Maintains: Outperform | 20 23 | 14.06 | 63.58% | 10 | Oct 22, 2024 | |
AUPH Aurinia Pharmaceutic... | Maintains: Outperform | 13 8 | 8.12 | -1.48% | 9 | Feb 16, 2024 | |
CRHM CRH Medical | Downgrades: Sector Perform | n/a | n/a | n/a | 1 | Feb 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sector Perform | n/a | n/a | n/a | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jul 20, 2016 |